In Vi Vo and in Vi Tro Screening of the Dyslipidemic Antihypertensives, Studying the Mechanism to Modulate Signaling Srebp and Ppar in the Renal Cells, and Investigating the Cotherapy with Mountain Celery Seed Aqueous Extract in Reducing Worsen Renal F(3/3)

Medicine & Life Sciences

1. 3-n-butylphthalide 17%
2. Adrenergic Antagonists 12%
3. Angiotensin Receptor Antagonists 11%
4. Angiotensin-Converting Enzyme Inhibitors 10%
5. Antihypertensive Agents 47%
6. Apium 100%
7. arabinogalactan 16%
8. Calcium 7%
9. Cardiovascular Diseases 7%
10. Cholesterol 7%
11. Chronic Renal Insufficiency 9%
12. Cricetinae 10%
13. Diuretics 10%
14. Dyslipidemias 30%
15. Fibrosis 15%
16. HDL Cholesterol 9%
17. Homeostasis 7%
18. Hypertension 13%
19. Kidney 60%
20. LDL Cholesterol 9%
21. Lipid Metabolism 9%
22. Lipids 6%
23. Molecular Mechanisms of Pharmacological Action 16%
24. Peroxisome Proliferator-Activated Receptors 24%
25. Polyphenols 11%
26. Pressure 6%
27. Proteinuria 9%
28. Renal Hypertension 12%
29. Seeds 63%
30. Signal Transduction 8%
31. Sterol Regulatory Element Binding Proteins 31%
32. Therapeutics 5%
33. Triglycerides 8%